Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer-Reference-Cited by-同舟云学术

Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer

Published:2021-07 Issue:3 Volume:36 Page:109394
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Dieter Sebastian M.^ORCID,Siegl Christine,Codó Paula L.,Huerta Mario,Ostermann-Parucha Anna L.,Schulz Erik,Zowada Martina K.^ORCID,Martin Sylvia,Laaber Karin^ORCID,Nowrouzi Ali,Blatter Mona,Kreth Sina,Westermann Frank,Benner Axel,Uhrig Ulrike,Putzker Kerstin,Lewis Joe^ORCID,Haegebarth Andrea,Mumberg Dominik,Holton Simon J.^ORCID,Weiske Joerg,Toepper Lena-Marit,Scheib Ulrike,Siemeister Gerhard,Ball Claudia R.,Kuster Bernhard,Stoehr Gabriele,Hahne Hannes^ORCID,Johannes Sarah,Lange Martin,Herbst Friederike,Glimm Hanno

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference59 articles.

1. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

2. The repertoire of mutational signatures in human cancer;Alexandrov;Nature,2020

3. Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity;Barette;Oncogene,2001

4. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens;Behan;Nature,2019

5. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes;Blazek;Genes Dev.,2011

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. Antitumoral activity of a CDK12 inhibitor in colorectal cancer through a liposomal formulation;Biomedicine & Pharmacotherapy;2024-09

3. Targeted protein degradation: current molecular targets, localization, and strategies;Drug Discovery Today;2024-09

4. Dual-site molecular glues for enhancing protein-protein interactions of the CDK12-DDB1 complex;Nature Communications;2024-08-01

5. Patientenabgeleitete 3-D-Tumormodelle;Die Onkologie;2024-06-11